Project Algulin – developing a recombinant algae that produces an oral insulin

University of Lethbridge iGEM (Lethbridge)

Project Algulin – creating an oral insulin solution

Team Grade Level: University
STEM Focus: Synthetic Biology

Diabetes is a disease that affects approximately 8.8% of the global population. Treatment currently involves the delivery of insulin by subcutaneous injection, which is painful and often very expensive for patients. Oral insulin alternatives have been deemed non-feasible because they are degraded in the stomach and thus the required dosage is too high. We chose to address this problem because the rising cost of insulin is garnering global media attention and we are passionate about both democratizing therapeutics and improving the quality of life for all diabetic patients.


Posted on

December 19, 2022

Subscribe to our news and updates.

Join our mailing list.

You have Successfully Subscribed!